Top compounds associated with response to KRI1


Feature Type Standardized
Nominal ANOVA
mRNA CD-437 CTRPv2 pan-cancer AAC 0.29 6e-15
mRNA STF-31 CTRPv2 pan-cancer AAC 0.31 1e-13
mRNA decitabine CTRPv2 pan-cancer AAC 0.23 9e-13
mRNA FK866 CTRPv2 pan-cancer AAC 0.3 2e-11
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 3e-11
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.24 6e-11
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.23 6e-11
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.25 3e-10
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC 0.21 3e-10
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.2 4e-10
Download CSV